OSRH
NASDAQ
$0.46
Bellevue Life Sciences Acquisition Corp (OSRH)
OSR Holdings Inc. is a prominent provider of integrated managed services, offering specialized asset management and financial advisory solutions tailored for institutional clients. By harnessing advanced technology and strategic partnerships, the company enhances operational efficiency while expanding its diverse array of services. With a commitment to sustainable growth and a client-centric approach, OSR Holdings distinguishes itself through innovative strategies and exceptional service quality. The firm maintains a proactive focus on emerging market opportunities and employs a comprehensive risk management framework, positioning it strategically for long-term stability and success for its stakeholders.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $10 (+2060.76%)
Market Cap
$14M
P/B Ratio
0.12
Free Cash Flow Yield
-37.65%
Beta (5Y)
0.13
Price Chart
Valuation
Market Cap$14M
P/S5.61
P/B0.12
Profitability
Total Revenue (TTM)$2.63M
Gross Profit (TTM)$548K
EBITDA-$19M
Operating Margin-758%
EPS-$0.78
Financial Health
Debt-to-Equity0.4%
Free Cash Flow Yield-37.65%
Growth & Risk
Beta (5Y)0.13
Sharpe Ratio0.20